Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival
Slamon, D.J., Neven, P., Chia, S., Jerusalem, G., De Laurentiis, M., Im, S., Petrakova, K., Valeria Bianchi, G., Martín, M., Nusch, A., Sonke, G.S., De la Cruz-Merino, L., Beck, J.T., Ji, Y., Wang, C., Deore, U., Chakravartty, A., Zarate, J.P., Taran, T., Fasching, P.A.
Published in Annals of oncology (01.08.2021)
Published in Annals of oncology (01.08.2021)
Get full text
Journal Article
Web Resource
Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant
Neven, P, Fasching, P. A, Chia, S, Jerusalem, G, De Laurentiis, M, Im, S.-A, Petrakova, K, Bianchi, G. V, Martín, M, Nusch, A, Sonke, G. S, De la Cruz-Merino, L, Beck, J. T, Zarate, J. P, Wang, Y, Chakravartty, A, Wang, C, Slamon, D. J
Published in Breast cancer research : BCR (31.08.2023)
Published in Breast cancer research : BCR (31.08.2023)
Get full text
Journal Article
Web Resource
Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL
Thill, M., Zahn, M.-O., Welt, A., Stickeler, E., Nusch, A., Fietz, T., Rauh, J., Wetzel, N., Kruggel, L., Jänicke, M., Marschner, N., Harbeck, N., Wöckel, A., Decker, T.
Published in Breast cancer research and treatment (01.04.2023)
Published in Breast cancer research and treatment (01.04.2023)
Get full text
Journal Article
Corrigendum to ‘Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival’: [Annals of Oncology Volume 32, Issue 8, August 2021, Pages 1015-1024]
Slamon, D.J., Neven, P., Chia, S., Jerusalem, G., De Laurentiis, M., Im, S., Petrakova, K., Valeria Bianchi, G., Martín, M., Nusch, A., Sonke, G.S., De la Cruz-Merino, L., Beck, J.T., Ji, Y., Wang, C., Deore, U., Chakravartty, A., Zarate, J.P., Taran, T., Fasching, P.A.
Published in Annals of oncology (01.10.2021)
Published in Annals of oncology (01.10.2021)
Get full text
Journal Article
Web Resource
Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib + fulvestrant: Results from MONALEESA-3
Fasching, P.A., Esteva, F.J., Pivot, X., Nusch, A., Beck, J.T., Chan, A., Pieris-Gunatilaka, A., Wang, Y., Lanoue, B., Chandiwana, D., Neven, P.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Ribociclib (RIB) + fulvestrant (FUL) for advanced breast cancer (ABC): Progression-free survival (PFS) subgroup and tumor response analyses from MONALEESA-3
Jerusalem, G., Fasching, P.A., Martín, M., Pivot, X., Petrakova, K., Bianchi, G.V., Nusch, A., Sonke, G.S., De La Cruz Merino, L., Vagnon, E., Alam, J., Kong, O., Chandiwana, D., De Laurentiis, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Testing for and frequency of molecular alterations in patients with advanced NSCLC in Germany. Results from the prospective German registry CRISP (AIO-TRK-0315)
Griesinger, F., Eberhardt, W.E.E., Nusch, A., Reiser, M., Bernhardt, C., Marschner, N., Jaenicke, M., Fleitz, A., Spring, L., Sahlmann, J., Karatas, A., Hipper, A., Weichert, W., Rittmeyer, A., Bischoff, H., Waller, C., Thomas, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1522 X-TREME: Interim analysis from a German open-label, observational non-interventional study for treatment persistence with denosumab in routine use in adults with bone metastases secondary to solid tumours
Diel, I.J, Hecker, D, Hesse, T, Kluike, C, Nusch, A, Rohrberg, R, Kurbacher, C, Rueckinger, S, Schilling, J, Schulz, H
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
119 UPDATE ON THE MULTICENTER MDS BIOREGISTRY PROJECT OF THE “KREBSHILFE-VERBUNDFORSCHUNGSPROJEKT MDS” OF THE GERMAN MDS STUDY GROUP
Schemenau, I, Strupp, C, Wulfert, M, Schroeder, T, Xicoy, B, Nusch, A, Langer, W, Kalhori, N, Haase, D, Brümmendorf, T, Schütte, J, Ganser, A, Parmentier, S, Schulte, K, Plewe, D, Losem, C, Biekmann, E, Hoffmann, W, Hahn, L, Neise, M, Lollert, A, Maintz, C, Hinske, C, Weißinger, F, Heudobler, D, Rodermann, E, Culmann, H, Kretschmar, T, Steinmetz, T, Giagounidis, A, Meckenstock, G, Runde, V, Haas, R, Germing, U, Hofmann, W.K, Gattermann, N
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
O-023 Did the prognosis of MDS patients improve during the last 30 years?
Neukirchen, J, Nachtkamp, K, Pfeilstöcker, M, Valent, P, Stauder, R, Blum, S, Lübbert, M, Haase, D, Götze, K, Hofmann, W.K, Schlenk, R, Giagounidis, A, Aul, C, Schulte, K, Lipke, J, Nusch, A, Krieger, O, Hegener, P, Weik, C, Letsch, A, Platzbecker, U, Kreutzer, K.A, Kobbe, G, Germing, U
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
5070 Real-life usage of capecitabine (X) for advanced breast cancer (ABC) in Germany: efficacy and safety results from a large (n = 870) non-interventional study
Siedentopf, F, Göhler, T, Nusch, A, Tobias, H, Sülberg, H
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
Advanced river quality monitoring in the Ruhr basin
Get full text
Conference Proceeding
Journal Article
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
Hortobagyi, Gabriel N, Stemmer, Salomon M, Burris, Howard A, Yap, Yoon-Sim, Sonke, Gabe S, Paluch-Shimon, Shani, Campone, Mario, Blackwell, Kimberly L, André, Fabrice, Winer, Eric P, Janni, Wolfgang, Verma, Sunil, Conte, Pierfranco, Arteaga, Carlos L, Cameron, David A, Petrakova, Katarina, Hart, Lowell L, Villanueva, Cristian, Chan, Arlene, Jakobsen, Erik, Nusch, Arnd, Burdaeva, Olga, Grischke, Eva-Maria, Alba, Emilio, Wist, Erik, Marschner, Norbert, Favret, Anne M, Yardley, Denise, Bachelot, Thomas, Tseng, Ling-Ming, Blau, Sibel, Xuan, Fengjuan, Souami, Farida, Miller, Michelle, Germa, Caroline, Hirawat, Samit, O’Shaughnessy, Joyce
Published in The New England journal of medicine (03.11.2016)
Published in The New England journal of medicine (03.11.2016)
Get full text
Journal Article
Restoration of fish passage: development and results of a master plan established for the Ruhr River Basin
Get full text
Journal Article
Conference Proceeding
CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer
Pivot, Xavier, Manikhas, Alexey, Żurawski, Bogdan, Chmielowska, Ewa, Karaszewska, Boguslawa, Allerton, Rozenn, Chan, Stephen, Fabi, Alessandra, Bidoli, Paolo, Gori, Stefania, Ciruelos, Eva, Dank, Magdolna, Hornyak, Lajos, Margolin, Sara, Nusch, Arnd, Parikh, Roma, Nagi, Fareha, DeSilvio, Michelle, Santillana, Sergio, Swaby, Ramona F, Semiglazov, Vladimir
Published in Journal of clinical oncology (10.05.2015)
Published in Journal of clinical oncology (10.05.2015)
Get full text
Journal Article
205P Pooled exploratory analysis of survival in patients (pts) with HR+/HER2- advanced breast cancer (ABC) and visceral metastases (mets) treated with ribociclib (RIB) + endocrine therapy (ET) in the MONALEESA (ML) trials
Yardley, D.A., Yap, Y.S., Azim, H.A., De Boer, R.H., Campone, M., Ring, A., De Laurentiis, M., O'Shaughnessy, J., Cortés, J., Chattar, Y., Thuerigen, A., Zarate, J.P., Nusch, A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
232P Second-line therapies of patients with early progression under CDK4/6-inhibitor in first-line – data from the registry platform OPAL
Marschner, N.W., Harbeck, N., Thill, M., Stickeler, E., Zaiss, M., Nusch, A., Rauh, J., Schulz, H., Engelken, K., Kruggel, L., Jänicke, M., Zahn, M-O., Wöckel, A., Welt, A., Decker, T.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
187P Routine care of early breast cancer (stage I-III) in Germany: Data of the prospective, intersectoral research platform OPAL
Welt, A., Zahn, M-O., Wöckel, A., Stickeler, E., Thoma, M., Nusch, A., Fuxius, S., Müller, L., Reschke, D., Chiabudini, M., Hillebrand, L., Kruggel, L., Jänicke, M., Marschner, N.W., Thill, M., Harbeck, N., Decker, T.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1542P First real-world outcome data of SCLC in Germany: Data from the Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315)
Sebastian, M., Reck, M., Fischer, R.N., Christoph, D.C.C., Bernhardt, C., von der Heyde, E., Nusch, A., Ludwig, P., Hipper, A., Hanselmann, J., Medinger, T., Binninger, A., Jänicke, M., Christopoulos, P., Elender, C., Bethge, A., Seese, B., Gauler, T.C., Waller, C.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
49P EGFR exon 20 insertion mutations in patients with locally advanced or metastatic NSCLC in the German prospective, CRISP Registry real-world cohort (AIO-TRK-0315)
Griesinger, F., Sebastian, M., Bethge, A., Christopoulos, P., Hoffknecht, P., Waller, C., Benkelmann, R., Jänicke, M., Fleitz, A., Hanselmann, J., Hipper, A., Groth, A., Weichert, W., Nusch, A., Rauh, J., Fietz, T., Illmer, T., Depenbusch, R., Eberhardt, W.E.E., Thomas, M.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article